Skip to main content


Investing in Health R&D

Investing in Health R&D


It is argued investment in R&D is crucial for better patient care and in turn economic growth. Yet figures show entrepreneurial risk in healthcare is often unrewarded and R&D expenditure in Europe is only half of the US with the private sector accounting for two-thirds of this investment.

Join the Health Policy Centre as it explores these realities and discover our in-depth analysis and reports on the topic.


“At Janssen we are on a quest to discover and develop innovative medicines and solutions that transform individuals’ lives – R&D investment is pivotal for us in this quest”

Paul Stoffels

Executive Vice President, Chief Scientific Officer J&J